Published in Clin Nephrol on July 01, 2009
The adipose tissue production of adiponectin is increased in end-stage renal disease. Kidney Int (2013) 0.93
Circulating adipocytokines and chronic kidney disease. PLoS One (2013) 0.89
Waist-to-Hip Ratio, Cardiovascular Outcomes, and Death in Peritoneal Dialysis Patients. Int J Nephrol (2010) 0.87
Circulating adiponectin is associated with renal function independent of age and serum lipids in west africans. Int J Nephrol (2012) 0.80
Hypoadiponectinemia correlates with arterial stiffness in kidney transplantation patients. Clin Exp Nephrol (2014) 0.80
Adiponectin receptor and adiponectin signaling in human tissue among patients with end-stage renal disease. Nephrol Dial Transplant (2014) 0.78
Elevated serum leptin, adiponectin and leptin to adiponectin ratio is associated with chronic kidney disease in asian adults. PLoS One (2015) 0.78
High adiponectin levels fail to protect against the risk of hypertension and, in women, against coronary disease: involvement in autoimmunity? World J Diabetes (2013) 0.78
Waist circumference as a predictor of adiponectin levels in peritoneal dialysis patients: a 12-month follow-up study. Perit Dial Int (2012) 0.76
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (2010) 11.55
Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA (2001) 8.56
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med (2013) 7.51
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis (2009) 5.82
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Evaluation of the notification procedure for physician-assisted death in the Netherlands. N Engl J Med (1996) 3.80
[Aortic involvement in patients with temporal arteritis and polymyalgia rheumatica]. Ned Tijdschr Geneeskd (2005) 3.01
Cot death and prone sleeping position in The Netherlands. BMJ (1989) 2.65
Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia (1996) 2.53
The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia (2010) 2.33
[Sudden death following a single oral administration of haloperidol]. Ned Tijdschr Geneeskd (2002) 2.32
Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med (2003) 2.28
Twenty-five years of experience with out-center hemodialysis. Kidney Int (1999) 2.24
Diabetes, prediabetes and cancer mortality. Diabetologia (2010) 2.22
The effect of exercise training programs on bone mass: a meta-analysis of published controlled trials in pre- and postmenopausal women. Osteoporos Int (1999) 2.20
Renal thrombotic microangiopathy induced by interferon-alpha. Nephrol Dial Transplant (2001) 2.20
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study. Diabetologia (2005) 2.16
Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care (2001) 2.15
'A man from Surinam....'. Nephrol Dial Transplant (1998) 2.02
Semi-automatic assessment of skin capillary density: proof of principle and validation. Microvasc Res (2013) 2.01
[Chronic renal disease as cardiovascular risk factor]. Ned Tijdschr Geneeskd (2008) 1.94
Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol (1996) 1.86
The (non-)sense of the methionine loading test for detecting hyperhomocysteinaemia. Neth J Med (2000) 1.77
Rates and risks for co-morbid depression in patients with Type 2 diabetes mellitus: results from a community-based study. Diabetologia (2003) 1.73
Insulin and risk of cardiovascular disease: a meta-analysis. Circulation (1998) 1.71
How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes? Diabetes Care (1999) 1.69
Prevalence and determinants of glucose intolerance in a Dutch caucasian population. The Hoorn Study. Diabetes Care (1995) 1.67
Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol (1999) 1.60
[Crib death in secondary prone position; symptoms and prevention]. Ned Tijdschr Geneeskd (1996) 1.58
Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care (1997) 1.57
von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study. Arterioscler Thromb Vasc Biol (1999) 1.57
In-training assessment: qualitative study of effects on supervision and feedback in an undergraduate clinical rotation. Med Educ (2006) 1.56
Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int (1998) 1.56
Prospective randomised trial of early dietary protein restriction in chronic renal failure. Lancet (1984) 1.53
Consultants in cases of intended euthanasia or assisted suicide in The Netherlands. Med J Aust (1999) 1.52
Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur J Gastroenterol Hepatol (1996) 1.52
Symptoms and well-being in relation to glycemic control in type II diabetes. Diabetes Care (1996) 1.51
Autonomic nervous function, arterial stiffness and blood pressure in patients with Type I diabetes mellitus and normal urinary albumin excretion. J Hum Hypertens (2004) 1.51
Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis (2008) 1.50
Subclinical renal dysfunction is independently associated with cardiovascular events in rheumatoid arthritis: the CARRÉ Study. Ann Rheum Dis (2011) 1.50
[Clinical application of albumin: a closer look at indications]. Ned Tijdschr Geneeskd (1997) 1.49
Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study. Circulation (2000) 1.46
Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia (2005) 1.46
Bacille Calmette-Guérin (BCG) meningitis in an AIDS patient 12 years after vaccination with BCG. Clin Infect Dis (1996) 1.46
Incidence of refeeding syndrome in internal medicine patients. Neth J Med (2016) 1.43
Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women. Clin Sci (Lond) (2003) 1.43
Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. Arterioscler Thromb Vasc Biol (1998) 1.42
Five-year incidence of type 2 diabetes mellitus in patients with familial combined hyperlipidaemia. Neth J Med (2010) 1.42
Both resistance- and endurance-type exercise reduce the prevalence of hyperglycaemia in individuals with impaired glucose tolerance and in insulin-treated and non-insulin-treated type 2 diabetic patients. Diabetologia (2011) 1.42
Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation (1999) 1.42
Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med (2005) 1.40
[Gallstones following considerable weight loss and recommendations for their prevention]. Ned Tijdschr Geneeskd (2004) 1.39
Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol (1995) 1.39
[Antibiotic prophylaxis in closed fractures is cost-effective if the possibility of a deep infection decreases through this by 0.25%]. Ned Tijdschr Geneeskd (1993) 1.39
[Anejaculation caused by haemosiderosis: male infertility in hereditary haemochromatosis]. Ned Tijdschr Geneeskd (2007) 1.38
Discontinuation of metformin in type 2 diabetes patients treated with insulin. Neth J Med (2002) 1.38
Effectiveness of clinical rotations as a learning environment for achieving competences. Med Teach (2004) 1.35
Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann Rheum Dis (2004) 1.30
Brisk walking compared with an individualised medical fitness programme for patients with type 2 diabetes: a randomised controlled trial. Diabetologia (2008) 1.29
Comparison of blood pressure measurement methods. Lancet (1997) 1.29
Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest (2003) 1.28
Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study. Diabetes (2000) 1.27
Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients. Arterioscler Thromb Vasc Biol (2002) 1.26
Refused and granted requests for euthanasia and assisted suicide in the Netherlands: interview study with structured questionnaire. BMJ (2000) 1.26
Smelling the diagnosis: a review on the use of scent in diagnosing disease. Neth J Med (2013) 1.23
Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes. Kidney Int (2008) 1.23
Low-grade inflammation can partly explain the association between the metabolic syndrome and either coronary artery disease or severity of peripheral arterial disease: the CODAM study. Eur J Clin Invest (2009) 1.22
The effect of metformin on blood pressure, plasma cholesterol and triglycerides in type 2 diabetes mellitus: a systematic review. J Intern Med (2004) 1.21
Sleeping position for infants and cot death in The Netherlands 1985-91. Arch Dis Child (1993) 1.20
Obesity-associated low-grade inflammation in type 2 diabetes mellitus: causes and consequences. Neth J Med (2013) 1.20
Delay in diagnosis of oral squamous cell carcinoma; a report from The Netherlands. Eur J Cancer B Oral Oncol (1992) 1.14
Alanine aminotransferase and the 6-year risk of the metabolic syndrome in Caucasian men and women: the Hoorn Study. Diabet Med (2007) 1.14
The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome--an analysis by structural equation modelling. Int J Obes Relat Metab Disord (2002) 1.13
Influence of nutritional factors and hemodialysis adequacy on the survival of 1,610 French patients. Am J Kidney Dis (2001) 1.12
Quantitation of reduced and total glutathione at the femtomole level by high-performance liquid chromatography with fluorescence detection: application to red blood cells and cultured fibroblasts. J Chromatogr B Biomed Sci Appl (2001) 1.11
[Guideline 'Cardiovascular Risk Management']. Ned Tijdschr Geneeskd (2007) 1.11
Effect of chemotherapy on survival of craniofacial osteosarcoma: a systematic review of 201 patients. J Clin Oncol (1997) 1.11
Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis. Arthritis Rheum (2001) 1.09
Coffee consumption and incidence of impaired fasting glucose, impaired glucose tolerance, and type 2 diabetes: the Hoorn Study. Diabetologia (2004) 1.09
5-Methyltetrahydrofolic acid and folic acid measured in plasma with liquid chromatography tandem mass spectrometry: applications to folate absorption and metabolism. Anal Biochem (2004) 1.08
Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study. Diabetologia (1996) 1.08
[Estimate of the number of new patients with type 2 diabetes mellitus in the Netherlands: at least 65,000 per year in the age group of 50 years and above]. Ned Tijdschr Geneeskd (2003) 1.08
Clinical significance of pepsinogen A isozymogens, serum pepsinogen A and C levels, and serum gastrin levels. Cancer (1987) 1.08
ESPEN Guidelines on Parenteral Nutrition: adult renal failure. Clin Nutr (2009) 1.07
Capillary recruitment is impaired in essential hypertension and relates to insulin's metabolic and vascular actions. Cardiovasc Res (2001) 1.07
Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes. Diabet Med (2007) 1.06
[Blood pressure control in patients with a symptomatic carotid artery stenosis]. Ned Tijdschr Geneeskd (2008) 1.06
Physiological hyperinsulinaemia increases intramuscular microvascular reactive hyperaemia and vasomotion in healthy volunteers. Diabetologia (2004) 1.06
Nephrectomy elicits impact of age and BMI on renal hemodynamics: lower postdonation reserve capacity in older or overweight kidney donors. Am J Transplant (2008) 1.06
Microvascular function is impaired in ankylosing spondylitis and improves after tumour necrosis factor alpha blockade. Ann Rheum Dis (2008) 1.05
Clinical significance of absent or reversed end diastolic velocity waveforms in umbilical artery. Lancet (1994) 1.05
Differences between anti-myeloperoxidase- and anti-proteinase 3-associated renal disease. Kidney Int (1995) 1.04
Current therapeutic interventions in the glycation pathway: evidence from clinical studies. Diabetes Obes Metab (2013) 1.04
[Microvascular dysfunction as an explanation for the metabolic syndrome]. Ned Tijdschr Geneeskd (2005) 1.04